Articles

This latest guidance provides a 15-year update on the recommendations, including the use of CGM devices.

FDA On Track to Update Diabetes Efficacy Endpoints Guidance

Facility upgrade will support clinical supply demand for CGT development. 

Catalent Adds Cryogenic Capabilities in Shiga, Japan

Jill Wechsler is ACT's Washington Correspondent

Agency hopes to update and improve its advisory committee composition and operations—to help FDA scientists “get the best advice possible.”

FDA Eyes Advisory Committee Reform to Enhance Credibility

Harsha K. Rajasimha, PhD, founder and executive chairman, IndoUSrare, provides the OCT audience insights into better achieving DEIA clinical trials.

OCT East 2023: Achieving Global DEIA in Clinical Trials

In this Q&A, Craig Lipset offers additional insights following the announcement that CVS will be closing its clinical trial services business by the end of the year. 

CVS's Closure of Its Clinical Trial Unit and What it Means for The Future

Allucent partners with THREAD to launch Allucent Patient Direct Trials, a DCT offering focused on small and mid-sized biotech companies.

Allucent Launches Decentralized Clinical Trial Solution

New solution delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity.

Suvoda Announces General Availability of New eCOA Solution

UCB will adopt Veeva ePRO and Veeva eConsent.

UCB and Veeva Announce Collaboration

New capability added to VIDA Intelligence Platform will streamline quality-controlled data curation.

VIDA Launches Cloud-Based Case Viewer

Latest enhancements will optimize Omnichannel capabilities for ROI reporting.

News